A detailed history of Alterity Financial Group, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alterity Financial Group, LLC holds 1,364 shares of LLY stock, worth $1.06 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
1,364
Previous 1,333 2.33%
Holding current value
$1.06 Million
Previous $715,000 11.19%
% of portfolio
1.14%
Previous 1.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $16,280 - $19,193
31 Added 2.33%
1,364 $795,000
Q3 2023

Oct 27, 2023

BUY
$434.7 - $599.3 $198,657 - $273,880
457 Added 52.17%
1,333 $715,000
Q2 2023

Jul 18, 2023

BUY
$350.74 - $468.98 $307,248 - $410,826
876 New
876 $410,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alterity Financial Group, LLC Portfolio

Follow Alterity Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alterity Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alterity Financial Group, LLC with notifications on news.